Literature DB >> 6180292

Reversible inhibition of RNA synthesis and irreversible inhibition of protein synthesis by D-galactosamine in isolated mouse hepatocytes.

J Mandl, K Mészáros, F Antoni, Z Spolarics, T Garzó.   

Abstract

The inhibition of RNA synthesis of isolated mouse liver parenchymal cells caused by 10 mM D-galactosamine was reversible, while the inhibition of protein synthesis remained unaltered after the removal of galactosamine. 10(-5)M epinephrine and 10(07)M glucagon have been shown to decrease aminoglycogen formation and thus to reduce the inhibitory effect of galactosamine on protein synthesis (II). However, these hormones did not decrease the inhibition of RNA synthesis. 10 mM D-galactosamine did not effect the nucleoside and amino acid incorporation of isolated non-parenchymal mouse liver cells. The predominant role of aminoglycogen in the inhibition of protein synthesis in galactosamine induced liver injury is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180292     DOI: 10.1007/bf00215578

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  INhibition of protein synthesis by hexosamine containing glycogen formed in mouse liver after treatment with D-galactosamine.

Authors:  K Mészáros; J Mandl; F Antoni; T Garzó
Journal:  FEBS Lett       Date:  1976-12-01       Impact factor: 4.124

2.  Studies on the inhibition of glycogenolysis by D-galactosamine in rat liver hepatocytes.

Authors:  S R Wagle; R Stermann; K Decker
Journal:  Biochem Biophys Res Commun       Date:  1976-07-26       Impact factor: 3.575

3.  Distribution of lysosomal enzymes between parenchymal and Kupffer cells of rat liver.

Authors:  T Berg; D Boman
Journal:  Biochim Biophys Acta       Date:  1973-10-10

4.  Effects of D-galactosamine on nucleotide metabolism and on microsomal membranes in mouse liver.

Authors:  K Mészáros; F Antoni; J Mandl; A Hrabák; T Garzó
Journal:  FEBS Lett       Date:  1974-08-25       Impact factor: 4.124

5.  Influence of liver-RES on toxic liver damage due to galactosamine.

Authors:  M Grün; H Liehr; W Grün; U Rasenack; D Brunswig
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1974-02

6.  Ultrastructural studies on D-galactosamine-HCl-induced liver injury in mice.

Authors:  K Lapis; Z Schaff
Journal:  Morphol Igazsagugyi Orv Sz       Date:  1973-08

7.  D-galactosamine and acute liver cell injury.

Authors:  H Shinozuka; J L Farber; Y Konishi; T Anukarahanonta
Journal:  Fed Proc       Date:  1973-04

8.  [Prevention of galactosamine hepatitis using administration of D-galactose: significance of temporally limited UDP-galactose deficit for the induction of galactosamine hepatitis].

Authors:  C Bauer; W Reutter; W Bachmann; R Lesch
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1972-10

9.  Experimental hepatitis induced by D-galactosamine.

Authors:  D Keppler; R Lesch; W Reutter; K Decker
Journal:  Exp Mol Pathol       Date:  1968-10       Impact factor: 3.362

10.  Incorporation of labelled amino acids into proteins of isolated parenchymal and nonparenchymal rat liver cells in the absence and presence of ethanol.

Authors:  J Mørland; A Bessesen; L Svendsen
Journal:  Biochim Biophys Acta       Date:  1979-02-27
View more
  2 in total

Review 1.  The ER - Glycogen Particle - Phagophore Triangle: A Hub Connecting Glycogenolysis and Glycophagy?

Authors:  József Mandl; Gábor Bánhegyi
Journal:  Pathol Oncol Res       Date:  2018-07-07       Impact factor: 3.201

2.  Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models.

Authors:  M Leist; F Gantner; I Bohlinger; G Tiegs; P G Germann; A Wendel
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.